Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-12-13

Clinical Trial Update: Safety and Efficacy Trial of Olanzapine in Outpatients With Pathological Gambling [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluated the safety and efficacy of olanzapine in outpatients with pathological gambling; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • olanzapine (olanzapine)

Snippet

Sponsor: Lindner Center of HOPE | Conditions: Pathological Gambling | Phase 3 | Status: COMPLETED